Advanced search
Publication Cover
Acta Oncologica Volume 42, 2003 - Issue 1
Journal homepage
150
Views
34
CrossRef citations to date
0
Altmetric
Research Article

FDG-PET-Detected Extracranial Metastasis in Patients with Non-Small Cell Lung Cancer Undergoing Staging for Surgery or Radical Radiotherapy

Michael P. Macmanus Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
,
Rodney Hicks Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
,
Richard Fisher Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
,
Danny Rischin Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
,
Michael Michael Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
,
Andrew Wirth Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
&
David L. Ball Departments of Radiation Oncology, Peter MacCallum Cancer Institute Victoria Melbourne
 show all
Pages 48-54 | Published online: 08 Jul 2009

  • Lewis P, Griffin S, Marsden P, et al. Whole-body 18-F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994; 44: 265-6.
  • Vansteenkiste JF, Stroobants SG, DeLeyn PR, et al. Lymph node staging in non-small cell lung cancer with FE)G-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-9.
  • Scott WJ, Schwabe JL, Gupta NC, et al. Positron emission tomography of lung tumors and mediastinal lymph nodes using {18F} fluorodeoxyglucose. Ann Thorac Surg 1994; 58: 698-703.
  • Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990's-meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-6.
  • MacManus M, Hicks R, Ball D, et al. FDG-PET staging in radical radiotherapy candidates with non-small cell lung cancer: powerful correlation with survival and high impact on treatment. Cancer 2001; 92: 886-95.
  • Weder W, Schmid RA, Bruchhaus H, et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1988; 66: 886-92.
  • MacManus M, Hicks R, Matthews J, et al. High rate of detection of unsuspected metastases by PET in apparent stage III NSCLC: implications for radical radiation therapy. Int J Radit Oncol Biol Phys 2001; 50: 287-93.
  • Erasmus JJ, Patz EF, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 1997; 168: 1361-2.
  • Bury T, Barreto A, Daenen F, et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 15: 1244-7.
  • MacManus MP, Wong K, Hicks RJ, et al. Early mortality following radical radiotherapy (RRT) for non-small cell lung cancer (NSCLC): Comparison of PET-staged and conventionally-staged cohorts treated at a large tertiary referral center. Int J Radiat Oncol Biol Phys 2002; 52: 351-61.
  • Hilsenbeck SG, Raub WA, Sridhar HS. Prognostic factors in lung cancer based on multivariate analysis. Am J Clin Oncol 1993;16:301-9.
  • Mountain CF. A new international staging system for lung cancer. Chest 1997; 111: 1711-7.
  • Grossi M, Millward M, Fisher R, et al. Combined modality treatment using concurrent radiotherapy and pharmacologically guided carboplatin for inoperable and incompletely resected non-small cell lung cancer. Lung Cancer 2001; 31: 73-82.
  • Karp JS, Muehllehner G, Mankoff DA, et al. Continuous-slice PENN-PET: a positron tomograph with volume imaging capability. J Nucl Med 1990; 31: 617-27.
  • Schiller JH, Harrington D, Chandra P, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 2002; 346: 92-8.
  • Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer 1989; 63: 1271-8.
  • Cullen MH, Billingham LJ, Woodroffe CM, et al. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 1999; 17: 3188-94.
  • Ball D, Smith J, Bishop J, et al. A phase III study of radiotherapy with and without continuous infusion fluorouracil as palliation for non-small cell lung cancer. Br J Cancer 1997; 75: 690-7.
  • Mclntosh MW. Instrumental variables when evaluating screening trials: estimating the benefit of detecting cancer by screening. Stat Med 1999; 18: 2775-94.
  • Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995; 311: 899-909.
  • Shahidi H, Kvale PA. Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer. Chest 1996; 109: 271-6.
  • Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494-500.
  • Luketich JD, Burt ME. Does resection of adrenal metastases from non-small cell lung cancer improve survival? Ann Thorac Surg 1996; 62: 1614.
  • O'Connell JP, Kris MG, Gralla RJ, et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 1986; 4: 1604-14.
  • Finkelstein DM, Ettinger DS, Ruckdeschel JC. Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1986; 4: 702-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.